Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Sell
14,300
-10,100
-41% -$1.15M ﹤0.01% 1806
2025
Q4
$2.46M Buy
24,400
+21,900
+876% +$2.38M 0.01% 1173
2025
Q3
$308K Buy
2,500
+400
+19% +$49.6K ﹤0.01% 2153
2025
Q2
$252K Buy
+2,100
New +$280K ﹤0.01% 1952
2024
Q4
Sell
-2,700
Closed -$439K 2523
2024
Q3
$439K Sell
2,700
-4,400
-62% -$652K ﹤0.01% 1644
2024
Q2
$968K Buy
+7,100
New +$986K 0.01% 1030
2023
Q4
Sell
-1,700
Closed -$222K 2402
2023
Q3
$222K Sell
1,700
-1,200
-41% -$182K ﹤0.01% 1788
2023
Q2
$461K Buy
+2,900
New +$468K ﹤0.01% 1398
2021
Q4
Sell
-2,300
Closed -$380K 3297
2021
Q3
$380K Buy
+2,300
New +$396K ﹤0.01% 2248

Other funds holding CLX

HRT Financial's CLX Position: Q3 2025 in Review

HRT Financial sold out of Clorox (CLX) in Q3 2025, closing a stake of 82,513 shares — an estimated $10.2M sold.

HRT Financial first reported a position in CLX in Q4 2018 and held it in 9 quarters. The position peaked at $34.3M in Q4 2024. 1,091 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

  • HRT Financial reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 82,513 Clorox shares in Q3 2025, an estimated $10.2M.
  • HRT Financial first reported a position in Clorox in Q4 2018 and held it in 9 quarters.
  • HRT Financial's Clorox position peaked at $34.3M in Q4 2024.
  • 1,091 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.